Authors: Hidalgo, M Aylesworth, C Hammond, LA Britten, CD Weiss, G Stephenson, J Schwartz, G Patnaik, A Smith, L Molpus, K Felton, S Gupta, E Ferrante, KJ Tortora, A Sonnichsen, DS Skillings, J Rowinsky, EK

Citation: M. Hidalgo et al., Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel, J CL ONCOL, 19(9), 2001, pp. 2493-2503

Authors: Norris, B Pritchard, KI James, K Myles, J Bennett, K Marlin, S Skillings, J Findlay, B Vandenberg, T Goss, P Latreille, J Rudinskas, L Lofters, W Trudeau, M Osoba, D Rodgers, A

Citation: B. Norris et al., Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8, J CL ONCOL, 18(12), 2000, pp. 2385-2394

Authors: Erlichman, C O'Connell, M Kahn, M Marsoni, S Torri, V Tardio, B Zaniboni, A Pancera, G Martignoni, G Labianca, R Barni, A Seitz, JF Milan, C Bedenne, L Giovannini, M Letreut, YP Skillings, J Shepard, L Zee, B Petrioli, R Francini, G

Citation: C. Erlichman et al., Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer, J CL ONCOL, 17(5), 1999, pp. 1356-1363